Resolution: standard / high
Figure 4.
Comparison of survival differences among HBsAg-negative DLBCL patients, HBsAg-positive DLBCL patients with normal liver function, and HBsAg-positive DLBCL patients with hepatic dysfunction during chemotherapy.
Wang et al. BMC Cancer 2008 8:115 doi:10.1186/1471-2407-8-115
Download authors' original image